Search - tctmd.com

Displaying 181 - 200 of 2435

Sort: Relevancy | Date

Presentation Interventional Complications 2024

How to Treat Under-Deployed Stents

Presenter: Lorenzo Azzalini

August 03, 2024

Presentation Interventional Complications 2024

Dry-field Closure Tools and Techniques for the Non-Structuralist: Balloon Occlusion, Radial-to-Peripheral Equipment, and Covered Stents

Presenter: Logan Vincent

August 02, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Presenter: Bernardo Cortese

May 14, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Presenter: Simon Eccleshall

May 14, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

Presentation Fellows 2024

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Presenter: Jeffrey W. Moses

April 13, 2024

Presentation Miami Valves 2024

Modern PCI: Achieve Optimal Treatment with AGENT DCB

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

AGENT™ Drug-Coated Balloon

Presenter: John M. Lasala

February 03, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

Presentation CTO 2024

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Presenter: Carlos Campos

February 03, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Miami Valves 2024

AGENT DCB Clinical Data

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Presentation Cardiovascular Interventions 2023

Conversations in Cardiology Decisions Are Not Always Black and White

Presenter: Morton J. Kern

November 10, 2023

Presentation Cardiovascular Interventions 2023

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation Cardiovascular Interventions 2023

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

Presenter: Paul S. Teirstein

November 10, 2023

Presentation Cardiovascular Interventions 2023

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Presenter: Ajay J. Kirtane

November 10, 2023

Advertisement

How to Treat Under-Deployed Stents

Dry-field Closure Tools and Techniques for the Non-Structuralist: Balloon Occlusion, Radial-to-Peripheral Equipment, and Covered Stents

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Methodological Insight: REC-CAGEFREE II Trial

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Modern PCI: Achieve Optimal Treatment with AGENT DCB

AGENT™ Drug-Coated Balloon

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

AGENT DCB Clinical Data

Conversations in Cardiology Decisions Are Not Always Black and White

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content